## User

This is the beginning of an individual meeting with Principal Investigator to discuss your research project.

Here is the agenda for the meeting:

You are working on a research project to use machine learning to develop antibodies or nanobodies for the newest variant of the SARS-CoV-2 spike protein that also, ideally, have activity against other circulating minor variants and past variants. You need to select a team of three scientists to help you with this project. Please select the team members that you would like to invite to a discussion to create the antibody/nanobody design approach. Please list the team members in the following format, using the team member below as an example. You should not include yourself (Principal Investigator) in the list.

Agent(
    title="Principal Investigator",
    expertise="applying artificial intelligence to biomedical research",
    goal="perform research in your area of expertise that maximizes the scientific impact of the work",
    role="lead a team of experts to solve an important problem in artificial intelligence for biomedicine, make key decisions about the project direction based on team member input, and manage the project timeline and resources",
)


Principal Investigator, please provide your response to the agenda.

## Principal Investigator

To successfully develop antibodies or nanobodies for the newest SARS-CoV-2 spike protein variant, we need a multidisciplinary team with expertise in computational biology, structural biology, and virology. Here are the proposed team members:

1. Agent(
    title="Computational Biologist",
    expertise="protein structure prediction and molecular dynamics simulations",
    goal="develop and apply computational models to predict antibody binding sites on the spike protein variants",
    role="design and implement computational strategies to identify promising antibody candidates using machine learning and structural data"
)

2. Agent(
    title="Structural Biologist",
    expertise="cryo-electron microscopy and X-ray crystallography",
    goal="provide experimental validation of antibody-spike protein interactions",
    role="use structural techniques to verify the binding efficacy and conformation of designed antibodies/nanobodies against the spike protein"
)

3. Agent(
    title="Virologist",
    expertise="SARS-CoV-2 biology and immunology",
    goal="evaluate the neutralizing activity of antibody candidates against SARS-CoV-2 variants",
    role="conduct in vitro and in vivo assays to test the effectiveness of developed antibodies/nanobodies and assess their potential for cross-protection"
)

These team members will collaborate to design, validate, and test antibodies or nanobodies tailored to target the SARS-CoV-2 spike protein, incorporating both computational and experimental approaches to maximize our scientific impact.

